International Journal of Medical Research & Health Sciences (IJMRHS)
ISSN: 2319-5886 Indexed in: ESCI (Thomson Reuters)
Shmeylan A. Alharbi
King Abdullah International Medical Research Centre, Ministry of National Guard Health Affairs, Riyadh 11481, Saudi ArabiaPublications
-
Research
Exploring Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Cancer Patients at a Tertiary-Care Hospital: Incidence, Symptoms and Risk Factors
Author(s): Wesam S. Abdel-Razaq*, Shmeylan A. Alharbi, Afnan M. Ibn Khamis, Amal H. Alnahdi, Amirah S. Alghanim, Areej M. Almutairi and Hessa H. Alqahtani
Background: Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a common adverse effect experienced by cancer patients receiving neurotoxic chemotherapy. The present study aimed to explore the incidence, symptoms, and risk factors associated with CIPN in cancer patients upon the completion of anticancer therapy. Study design: The European Organization of Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-CIPN20), implemented explicitly for cancer patients, was used to assess CIPN symptoms and severity. This survey evaluates CIPN symptoms related to three domains: sensory, motor, and autonomic functions. Results: A total of 357 patients’ records were included with a median age of 53.0 years (range 15-90). The most reported symptoms among respondents were tingling and numbness in the upper and/or lower extr.. Read More»
DOI: -
Select your language of interest to view the total content in your interested language